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Abstract
Otitis media (OM) is one of the most common pediatric infections worldwide, but the complex microbiology associated with OM
is poorly understood. Previous studies have shown an association between OM and gastroesophageal reflux (GER) in children.
Therefore, in order to bridge the gap in our current understanding of the interaction between GER and OM, we investigated the
nasopharyngeal and middle ear microbiota of children suffering from GER-associated OM and OM only, using culture-
independent 16S rRNA gene sequencing. Middle ear fluid, nasopharyngeal swabs, and clinical data were collected as part of a
prospective pilot study conducted at the Department of Otorhinolaryngology of the Erasmus MC-Sophia Children’s Hospital,
Rotterdam, the Netherlands. A total of 30 children up to 12 years of age who suffered from recurrent acute otitis media (AOM)
(5), chronic otitis media with effusion (OME) (23), or both (2), and who were listed for tympanostomy tube placement, were
included in the study. Nine children were included in the GER-associated OM cohort and 21 in the OM-only cohort. We found no
obvious effect of GER on the nasopharyngeal and middle ear microbiota between the two groups of children. However, our
results highlight the need to assess the true role of Alloiococcus spp. and Turicella spp. in children presenting with a high
prevalence of recurrent AOM and chronic OME.
Introduction
Respiratory tract infections are the leading causes ofmorbidity
and death in children and adults worldwide, with otitis media
(OM) being one of the most prevalent pediatric respiratory
tract infections [1]. OM causes severe pain and can lead to
serious complications, such as meningitis, mastoiditis, and
hearing loss. As an example, OM-related hearing impairment
has a prevalence of 30.82 per 10,000, and, each year, 21,000
people die due to complications of OM (estimated from 21
World Health Organization [WHO] regional areas) [2].
Importantly, the pathogenesis of OM is multifactorial, involv-
ing genetic, microbiological, and environmental factors [3].
A potentially important, though relatively unknown, factor
to be associated with OM is gastroesophageal reflux (GER).
GER, also known as acid reflux, is a clinical manifestation in
which the stomach’s contents return back up into the esopha-
gus and mouth. Reflux is a normal process that occurs in
healthy infants, children, and adults. Most episodes are brief
and do not cause bothersome symptoms or complications.
However, earlier studies have shown a strong association be-
tween GER and OM [4–6]. The mean prevalence of GER in
children with (chronic) OM with effusion (OME) is 48% and
in children with (recurrent) acute OM (AOM) 63%, while the
mean prevalence of GER in healthy children is less than 10%
[7]. The data suggest a role for GER in the multifactorial
etiology of OM in children, a hypothesis strengthened by the
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detection of pepsin and bile acids in the middle ears of chil-
dren presenting with OM [4–6], as well as the possible role of
Helicobacter pylori in the etiology of OM [8–11]. However,
to date, no one has used culture-independent techniques to
investigate the possible influence of GER on the nasopharyn-
geal and middle ear microbiota in GER-prone children. In this
respect, differences in the presence or absence of (specific)
microorganisms in the middle ear of GER-prone versus
GER non-prone children could help further establish a role
for GER in the pathogenesis of OM.
Therefore, in order to bridge the gap in our current under-
standing of the interaction between GER and OM, we inves-
tigated the nasopharyngeal and middle ear microbiota of chil-
dren suffering from GER-associated OM and OM only, using
culture-independent 16S rRNA gene sequencing.
Materials and methods
Middle ear fluid (MEF), nasopharyngeal swabs (NPS), and clin-
ical data were collected according to Klokkenburg et al. [4] and
Stol et al. [12], as part of a prospective pilot study conducted at
the Department of Otorhinolaryngology of the Erasmus MC-
Sophia Children’s Hospital, Rotterdam, the Netherlands.
Children with a history of craniofacial malformations/syn-
dromes, or primary or acquired immune deficiency were exclud-
ed from participation. Questionnaires were used to obtain rele-
vant patient characteristics from the parents of the GER-
associated OM cohort and the OM-only cohort. The GER-
associated cohort was defined via questionnaires based on the
questions BHas your child been diagnosed with reflux in the
previous three months?^ and BHas your child been diagnosed
with reflux in the past?^ The studywas approved by the Erasmus
MC Medical Ethical Committee (MEC-2012-487). Written
informed consent was obtained from parents or caregivers.
Microbiota profiles were analyzed using next-generation se-
quencing of hypervariable V5-V6 regions of the 16S rRNA
gene, as previously described [13]. Prior to 16S rRNA gene
sequencing, the total number of 16S rRNA gene copies within
each DNA extraction was measured using a 16S quantitative
polymerase chain reaction (PCR) according to Yang et al. [14].
This was performed in order to remove any specimens from the
analysis where the contaminating bacterial DNA that is already
present within chemicals and consumables used in the experi-
mental procedure could be responsible for the results obtained.
In this respect, all specimens that contained < 1000 16S rRNA
gene copies/μL were not sequenced [15]. All sequence data
obtained from specimens containing > 1000 16S rRNA gene
copies/μL was processed using bioinformatics modules present
in the mothur v.1.33.0 software package [16].
Statistical analyses were performed using IBM SPSS
Statistics 21. Fisher’s exact test was used to calculate the sta-
tistical differences between patient baseline characteristics,
differences between antibiotic use and specimen exclusion,
antibiotic use, and pathogen detection, and to calculate the
statistical differences of prominent middle ear microbiota be-
tween GER-prone and GER non-prone children. A p-value of
≤ 0.05 was considered to be statistically significant.
Data availability The datasets generated and analyzed during
the current study are available in the NCBI Sequence Read




16S rRNA gene sequencing
Thirty children up to 12 years of age who suffered from re-
current AOM (5), chronic OME (23), or both (2), and who
were listed for tympanostomy tube placement, were included
in the study (Table 1). Children were diagnosed based on the
surgeon’s report.
In total, 11/30 MEF specimens and 11/30 NPS specimens
(not, by definition, paired specimens) were excluded from 16S
rRNA gene sequencing due to low DNA content (< 1000 16S
rRNA gene copies/μL). Antibiotic use ≤ 6 months prior to
inclusion in the study did not affect the exclusion of samples
due to low DNA content (Table 2; MEF p = 0.13, NPS p =
0.45). The microbial composition of the remaining 38 speci-
mens were sequenced and the data were processed using
mothur. To reduce the effects of uneven sequencing depths,
sequences were rarefied to 1000 sequences per specimen,
which was sufficient to obtain a high degree of sequence cov-
erage with an average Good’s coverage value of 0.98 (± 0.01).
Sequencing of the MEF microbiota resulted in the identifi-
cation of 29 bacterial operational taxonomic units (OTUs) in
19 MEF specimens with an abundance > 1%, with an average
of 4 OTUs (± 3) per specimen. Sequencing the nasopharyn-
geal microbiota identified 39 bacterial OTUs in 19 NPS spec-
imens with > 1% abundance, with an average of 9 OTUs (± 4)
per specimen.
Characterization of middle ear bacterial communities
The most commonly detected OTUs were Alloiococcus spp.
and Turicella spp., present in 12 and 11 MEF specimens,
respectively. There has been some debate as to whether mem-
bers of the bacterial genera Alloiococcus and Turicella actual-
ly play a role in the pathogenesis of OM in children or if they
are part of the commensal microbiota (and invading the mid-
dle ear following perforation) [17–23]. Though A. otitidis and
T. otitidis are frequently detected in OM children, it is ques-
tionable whether these organisms have enough pathogenic
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potential to induce OM, although studies have shown that
A. otitidis may have enough immunogenic potential to mod-
ulate a host immune response [24–26]. In addition, A. otitidis
is able to form both single- and multispecies biofilms with
Haemophilus influenzae. When present in polymicrobial
biofilms, A. otitidis can promote H. influenzae growth and
survival by increasing biofilm production in adverse growth
conditions and by altering antimicrobial resistance [27]. In this
study, the use of antibiotics ≤ 6months prior to inclusion in the
study did not have an effect on the detection of Alloiococcus
spp., Haemophilus spp., Streptococcus spp., or Moraxella
spp. (Table 3). These findings are clinically important, as an-
tibiotics overuse or misuse can promote the development of
bacterial resistance to antibiotics. Alloiococcus spp. and
Turicella spp. were not detected by 16S rRNA gene sequenc-
ing in any nasopharyngeal swab. Previous PCR- and culture-
based studies from other populations have reported A. otitidis
in 7–12% of nasopharyngeal swabs, in contrast to the study of
Marsh et al., who found no A. otitidis in paired nasopharyn-
geal swabs [17, 18, 28, 29]. Turicella otitidis is isolated almost
exclusively from middle ear exudates [20, 23]. However, our
study was limited to 30 children and it is possible that
Alloiococcus spp. and Turicella spp. would have been detect-
ed in a larger cohort of children. Failure to detect Alloiococcus
spp. and Turicella spp. in nasopharyngeal swabs from any of
the children with positive ear MEF samples suggests that they
are unlikely to be primary otopathogens in this population,
since nasopharyngeal colonization is considered to be the an-
tecedent of OM [30]. To better understand the potential role of
Alloiococcus spp. and Turicella spp. in OM, further studies
into host interactions and colonization of adjacent sites in
healthy and diseased children will be necessary. Ultimately,
the findings of this study will need to be further validated in
the future with larger cohort sizes.
OTUs consistent with classical otopathogens such as
Haemophilus spp., Streptococcus spp., and Moraxella
spp. were detected in 9, 6, and 1 MEF specimens, respec-
tively (Fig. 1). In addition, staphylococci were also found
in the MEF of seven children, with an abundance up to
100%. Our findings are consistent with several other stud-
ies; for example, Haemophilus (influenzae) has been
found to be the most common pathogen isolated in the
context of widespread conjugate pneumococcal vaccina-
tion [31, 32]. Further, the presence of Haemophilus
(influenzae) has been associated with an increased risk
of OM, whereas the presence of Corynebacterium spp.
and Dolosigranulum spp. have been associated with a
decreased risk of OM [33, 34].
No upper gastrointestinal tract microbiota previously asso-
ciated with OM (e.g., H. pylori) was detected in the middle
ear. Further, we did not find any microbial difference in the
MEF of children with or without GER (Table 4), suggesting
Table 1 Demographic and
clinical parameters stratified by
the gastroesophageal reflux
(GER)-associated otitis media
(OM) cohort (n = 21) and the
OM-only cohort (n = 9)
No GER, n = 21 (%) GER, n = 9 (%) p-Value
Demographic parameters
Male sex 13 (61.9) 5 (55.6) 1
Age, years 5.3 [1.3–6.0] 3.7 [0.8–12.8]
Antibiotics ≤ 6 months preceding inclusion 12 (57.1) 5 (55.6) 1
Siblings 16 (76.2) 5 (55.6) 0.39
Day-care 7 (33.3) 7 (77.8) 0.05
Smoking 14 (66.7) 5 (55.6) 0.69
Breastfeeding 11 (52.4) 8 (88.9) 0.10
Diagnosis
OME 16 (76.2) 7 (77.8) 1
rAOM + (OME) 5 (23.8) 2 (22.2) 1
Ventilation tube placement in past 11 (52.4) 1 (11.1) 0.05
Adenotonsillectomy in past 7 (33.3) 0 (0) 0.07
Table 2 Inclusion and exclusion
of samples related to antibiotic
use ≤ 6 months preceding
inclusion
MEF p-Value NPS p-Value
Inclusion Exclusion Inclusion Exclusion
Antibiotics 13 4 0.13 12 5 0.45
No antibiotics 6 7 7 6
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that GERwas not associated with the translocation of stomach
microbiota to the middle ear in our cohort.
Co-occurrence of OM-related pathogens
To study the co-occurrence of OM-related pathogens in the
nasopharynx and middle ear, we compared the microbiota
obtained from 12 paired NPS and MEF specimens (Fig. 2).
Nine OTUs were present in both specimen types, of which
four OTUs, including Haemophilus spp., Streptococcus spp.,
Parvimonas spp., and Staphylococcus spp. were present in
both paired specimen types from 10/12 children.
Importantly, Haemophilus spp. and Streptococcus spp. were
only detected in MEF when the nasopharynx of the child was
concurrently colonized with these bacterial genera. This find-
ing is in agreement with previous studies, and suggests that the
more easily accessible nasopharyngeal microbiota could be
used to predict the presence of pediatric otopathogens in the
middle ears of children suffering from OM. However, it
should be noted that the majority of OTUs, including the
dominant genera Alloiococcus spp. and Turicella spp.,
were unique to the sampling site and, therefore, caution
is necessary when using the nasopharyngeal microbiota as
a proxy for the MEF microbiota, as discussed previously
by van Dongen et al. [35].
Strengths and limitations of the study
The strength of this publication is that it is the first study to
investigate the possible association between the microbial
composition of the nasopharynx and middle ear in GER-
prone and GER non-prone children using culture-free 16S
rRNA gene sequencing. However, several limitations in the
study protocol should be recognized.
Firstly, an actual diagnosis of GER is difficult to prove, as
most cases of pediatric GER are diagnosed based solely on the
clinical presentation and parental observation (and not, for ex-
ample, on the presence of pepsin and bile acids in the middle
ear). There are no recognized classic physical signs of GER in
the pediatric population, and, in general, a doctor diagnoses
GER by reviewing an infant’s symptoms and medical history.
In this study, only parental-reported clinical information was
collected. Essentially, we asked parents retrospectively if their
child was diagnosed with reflux in the previous three months
Fig. 1 Heatmap demonstrating the relative abundance of bacterial taxa in
individual middle ear fluid (MEF) specimens. Bacterial operational
taxonomic units (OTUs) are grouped and shown at the genus level,
unless the OTU was not identified below the taxonomic order level (Δ).
A cut-off of 1% abundance was used for visual differentiation between
specimens. The number of merged OTUs is shown in parentheses.
Children that suffered from gastroesophageal reflux (GER) are indicated
with an asterisk
Table 3 Antibiotic use and pathogen detection in middle ear fluid (MEF)
Pathogen No. of specimens









Alloiococcus spp. 2 0 0.07 3 7 1
Streptococcus spp. 0 1 1 1 4 1
Haemophilus spp. 1 1 1 1 6 0.27
Moraxella spp. 0 0 1 0 1 1
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and if their child had been diagnosed with reflux at any time in
the past. To date, the most thoroughly evaluated questionnaire
for infant symptoms is the Infant Gastroesophageal Reflux
Questionnaire Revised (I-GERQ-R) [36]. We designed our
own questionnaire, as even an established questionnaire such
as the I-GERQ-R was not validated to be adequately specific to
differentiate GER infants from other symptomatic, but non-
GER, infants, particularly if the treatments being tested are
directed at acid reflux. For that purpose, additional inclusion
criteria, such as esophageal pH monitoring or histology, are
currently necessary to ensure adequate diagnostic specificity
[36]. In the current study, we did not confirm the parental-
reported diagnosis of GER by the identification of bile acids/
pepsin in MEF or measurement of the MEF pH levels. These
tools have proven to be useful for determining the presence of
pathological GER [4–6]. The absence of these tools in our
study may have influenced the fact that we found no statistical-
ly significant association between the microbiota profiles of
GER-prone and GER non-prone children.
Secondly, our study included only children primarily diag-
nosed with OME, as these children are mainly listed for
tympanostomy tube placement. Most children with AOM ex-
perience a self-limiting illness and lack the presence of fluid in
the middle ear. Many will not present to a doctor. This means
that an association between GER and AOM disease is much
more difficult to prove than between GER and OME disease,
but does not affect the hypothesis that GERmay be associated
with increased OM disease in GER-prone children.
Thirdly, as previously discussed, using the more easily ac-
cessible nasopharyngeal microbiota to predict the presence of
pediatric otopathogens in the middle ears of children suffering
from OME and AOM is questionable. Because of the size of
the population studied and lack of data from other studies, data
interpretation should be made with caution and regarded as
preliminary. Further, we were unable to analyze the
Fig. 2 Co-occurrence model showing bacterial taxa present within 12
paired nasopharyngeal (NPS) and middle ear fluid (MEF) specimens.
Data (Cytoscape v3.2.1) [37] are presented for 12 children, and include
a single NPS and MEF specimen per patient. Taxonomic assignment for
each OTU is at the genus level, unless the OTU was not identified below
the taxonomic order level (*). A cut-off of 1% abundance was used for
visual differentiation between both specimen types. Bracketed numbers
[NPS/MEF] and node sizes indicate the number of specimens that contain
a specified OTU. Shared OTUs are visualized in the middle and
connected by a line if the presence of an OTU in both specimen types
was derived from the same patient (solid) or from different children
(dashed). Specimen-specific OTUs are grouped at the genus or order
levels to ease visualization
Table 4 Effect of GER on the presence of prominent middle ear
microbiota
Pathogen No. of specimens
GER (n = 6) No GER (n = 13) p-Value
Alloiococcus spp. 2 10 0.13
Haemophilus spp. 2 7 0.66
Streptococcus spp. 1 5 0.60
Moraxella spp. 0 1 1
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microbiota to the species level (a common problem with mi-
crobiota analysis [13]) and were, therefore, limited to bacterial
taxonomic identification at the genus level.
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